바로가기 메뉴
본문 바로가기
푸터 바로가기
TOP

Shin, Young Kee

Professor

Shin, Young Kee

02-880-9126
ykeeshin@snu.ac.kr
0000-0003-0896-718X
Academic Experience

· 1996 : Bachelor of Science in Medicine, Seoul National University College of Medicine (MD)

· 1998 : Master of Science in Medicine, Seoul National University College of Medicine ((MS)

· 2000 : Doctor of Philosophy in Medicine, Seoul National University College of Medicine (PhD)

· 2001~2004 : Postdoctoral Fellow, Seoul National University College of Medicine (Postdoc)

· 2004~ 2008 : Assistant Professor, College of Pharmacy, Seoul National University

 ·2008~ 2014 : Associate Professor, College of Pharmacy, Seoul National University

 ·2008~ Present : Professor, College of Pharmacy, Seoul National University

 ·20132016 : Director,  Research Center for Personalized Cancer Medicine

 ·2016~ Present : Professor, Department of Molecular Medicine Biopharmaceutical Sciences, Graduate School of Convergence Science                                      and Technology, Seoul National University

 ·2019~ 2024 : Dean, Department of Molecular Medicine Biopharmaceutical Sciences, Graduate School of Convergence Science and                                     Technology, Seoul National University

  ·2020~ Present : Director, Startup Support Program for Biotechnology, Strategic Planning Division, Seoul National University Siheung                                          Campus

 ·2024~ Present  : Director, Siheung Campus and Director of the Future Innovation Research Institute, Seoul National University

Entrepreneurial Experience

·  2010~ Present : Founder & CEO of Abion  

 · 2016~ Present : Founder & Board Member, ROGONE Bio Research Convergence Center

Achievements & Awards

[Patents]
·  Registration:   Domestic : 38 cases,  Overseas : 107cases

 · ApplicationDomestic : 18 cases,  Overseas : 54 cases

[Articles]
· 190 papers

 [Technology transfer and commercialization]

· Technology transfer26 cases

· Commercialization:   3 cases

       

[Awards]
             –  Lee Eun-bang Prize for Outstanding Achievements in New Drug Development (26, Oct., 2023)